Drug intelligence / Profile preview

bifidobacterium longum KB35

Development stage
Unknown
Lead developer
Kibow Biotech
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

Bifidobacterium longum KB35 is a specific probiotic bacterial strain developed by Kibun Foods Inc. for the management of hyperuricemia and gout. The strain is characterized by its high purine-degrading activity, specifically targeting purine nucleosides such as inosine and guanosine within the intestinal lumen. By breaking down these substrates before they can be absorbed into the systemic circulation, KB35 reduces the availability of precursors for hepatic uric acid synthesis, thereby lowering serum uric acid levels. Clinical investigations in Japan have evaluated KB35 as a live biotherapeutic product or functional food ingredient to assist in the control of asymptomatic hyperuricemia and prevent the onset of gouty arthritis.

Other names
Bifidobacterium longum strain KB35

Beyond the preview

Go deeper on bifidobacterium longum KB35.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bifidobacterium longum KB35.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call